About
Beofor Research Consulting partners with venture-backed biotech and emerging pharma companies to turn ambitious science into disciplined, capital-efficient operational reality.
Founded by Debra Mitchell, PhD, former Director and Global Program Leader at Johnson & Johnson Innovative Medicine and Eli Lilly, Beofor provides Fractional COO services for Series A/B and beyond, embedding with leadership teams to drive Phase II–IV execution, optimize CRO and vendor governance, and build inspection-ready operating models.
We also advise on Medical Affairs strategy, including publication planning, KOL engagement, and evidence generation.
Enterprise rigor. Without enterprise drag.
Details
- Website: https://beofor.ca
- Founded: 2025
- Company Size: 1 employees
- Headquarters: Greater Toronto Area
- Specialties: Fractional COO / Interim Executive Leadership, Clinical Operations Strategy & Management, Portfolio & Program Prioritization, CRO & Vendor Optimization, Regulatory Readiness & Inspection Support, Milestone-Driven Clinical Execution, Lean & Scalable Clinical Infrastructure, Operational Risk Mitigation & Governance, Clinical Trial Innovation & Digital Integration, Team Development & Cross-Functional Leadership, IND & Phase Transition Planning, Early-Stage Biotech Program Design, Clinical Strategy, Oncology & Hematology Clinical Programs, Immunology & Neuroscience Trials, Cell & Gene Therapy Development, Budget Optimization & Cost Control, Trial Start-Up Acceleration, Process Optimization & Operational Efficiency, Investor & Board-Level Reporting Support, Medical Affairs